#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cortisol levels are more closely associated with depressiveness and other psychopathologies than catecholamine levels


Authors: Z. Hess 1;  J. Podlipný 2;  H. Rosolová 1;  O. Topolčan 3;  B. Petrlová 1
Authors‘ workplace: II. interní klinika Lékařské fakulty UK a FN Plzeň, přednosta doc. MUDr. Jan Filipovský, CSc. 1;  Psychiatrická klinika Lékařské fakulty UK a Plzeň, přednosta doc. MUDr. Jiří Beran, CSc. 2;  Oddělení imunoanalýzy Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Ondřej Topolčan, CSc. 3
Published in: Vnitř Lék 2007; 53(10): 1040-1046
Category: Original Contributions

Overview

Objective:
Quantification of changes in the levels of the above hormones, i.e. cortisol, adrenalin, noradrenalin and dopamine depending on the presence of depressive symptoms and other psychopathological symptoms. Sample: 259 randomly selected individuals from the population of the city of Pilsen.

Method:
Zung self-assessment scale and SCL-90 questionnaire were used to assess depressiveness and other psychopathologies. Serum cortisol levels were measured, as well as the levels of cortisol and catecholamine (adrenalin, noradrenalin and dopamine) in a 24-hour urine sample. The studied sample was divided, by an arbitrarily defined limit, into a group with a higher and a group with a lower excretion of the monitored hormones.

Results:
The group with cortisol excretion higher than 300 nmol/24 h had a significantly higher score in terms of the SCL-90 questionnaire interpersonal sensitiveness, depression, anxiety, phobia, paranoidism and psychoticism as compared with the group with cortisol excretion below 300 nmol/24 h (p < 0.05). The group with cortisol excretion above 300 nmol/24 h had also a significantly higher score on Zung’s self-assessment depression scale as compared with the group with cortisol excretion below 300 nmol/24 h (p < 0.05). Division of the sample according to the score on Zung’s self-assessment depression scale (SDS index ł 50) has shown that women with a record of depressive symptoms had a statistically significant higher of urinary cortisol excretion in 24 hours (average 219.40 as compared with 191.64 nmol/24 h, respectively, p = 0.02). The group of men with depressive symptoms according to the score obtained on Zung self-assessment scale only showed a trend towards higher urinary noradrenalin excretion in 24 hours (average of 69.77 as compared with 63.84 μg/24 h, p = 0.17).

Conclusion:
As shown by the above results, there is a link between 24-hour urinary cortisol excretion levels and the monitored parameters of psychic condition.

Keywords:
depression – cortisol – catecholamines


Sources

1. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington (DC): American Psychiatric Association 1994.

2. Delay J, Lainé B, Buisson JF. Note concernant l’action de l’isonicotinylhydrazide dans le traitement des etats dépressifs. Ann Med Psychol (Paris) 1952; 110: 689-692.

3. Yamada M, Yasuhara H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 2004; 25: 215-221.

4. Saura JM, Kettler R, Da Prada M et al. Molecular neuroanatomy of MAO-A and MAO-B. J Neural Transm 1990; 32: 49-53.

5. Ehlwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 435-451.

6. Varghese FP, Brown ES. The hypothalamic-pituitary-adrenal axis in major depressive disorder: a brief primer for primary care physicians. Prim Care Companion J Clin Psychiatry 2001; 3: 151-155.

7. Stokes PE. The potencial role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 1995; 5(Suppl 1): 77-82.

8. Thomas L (ed). Labor und Diagnose. 4. ed. Marburg: Die Medizinische Verlagsgesellschaft 1995.

9. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41: 105-114.

10. Zung WW. A Self-Rating Depression Scale. Arch Gen Psychiatry 1965; 12: 63-70.

11. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull 1973; 9: 13-28.

12. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.

13. Harris T. Depression in women and its sequelae. J Psychosom Res 2003; 54: 103-112.

14. Makaremi A. Sex differences in depression of Iranian adolescents. Psychol Rep 1992; 71: 939-943.

15. Young AH, Sahakian BJ, Robbins TW et al. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 1999; 145: 260-266.

16. Wolkowitz OM, Reus VI, Chan T et al. Antiglucocorticoid treatment of depression: double blind ketoconazole. Biol Psychiatry 1999; 45: 1070-1074.

17. Schweiger U, Deuschle M, Webber B et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999; 61: 292-296.

18. Weber B, Lewicka S, Deuschle M et al. Increased diurnal plasma concentrations of cortisone in depressed patients. J Clin Endocrinol Metab 2000; 85: 1133-1136.

19. Gold PW, Wong ML, Goldstein DS et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA 2005; 102: 8303-8308.

20. Rao U, McCracken J, Lutchmansingh P et al. Electroencephalographic sleep and urinary free cortisol in adolescent depression: a preliminary report of changes from episode to recovery. Biol Psychiatry 1997; 41: 369-373.

21. Rao U, Dahl RE, Ryan ND et al. The relationship between longitudinal clinical course and sleep and cortisol changes in adolescent depression. Biol Psychiatry 1996; 40: 474-484.

22. Catalán R, Gallart JM, Castellanos JM et al. Plasma corticotropin-releasing factor in depressive disorders. Biol Psychiatry 1998; 44: 15-20.

23. Hughes JW, Watkins L, Blumenthal JA et al. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res 2004; 57: 353-358.

24. Fujita H, Hata K, Ogata E et al. Spot determinations of urinary cortisol for the screening of Cushing’s syndrome. Endocrinol Jpn 1991; 38: 441-444.

25. Maes M, Calabrese J, Meltzer HY. The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 503-517.

26. Lupien S, Lecours AR, Schwartz G et al. Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging 1996; 17: 95-105.

27. Otte C, Neylan TC, Pipkin SS et al. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry 2005; 162: 2139-2145.

28. Reuben DB, Talvi SL, Rowe JW et al. High urinary catecholamine excretion predicts mortality and functional decline in high-functioning, community-dwelling older persons: MacArthur Studies of Successful Aging. J Gerontol A Biol Sci Med Sci 2000; 55: M618-M624.

29. Cohn JN, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.

30. Christensen NJ, Schultz-Larsen K. Resting venous plasma adrenalin in 70-year-old men correlated positively to survival in a population study: the significance of the physical working capacity. J Intern Med 1994; 235: 229-232.

31. Anand IS, Fisher LD, Chiang YT et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.

32. Mann DL, Kent RL, Parsons B et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992; 85: 790-804.

33. Meredith IT, Broughton A, Jennings GL et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1990; 325: 618-624.

34. Podrid PJ, Fuchs T, Candinas R Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990; 82: I103-I113.

35. Benedict CR Neurohumoral aspects of heart failure. Cardiol Clin 1994; 12: 9-23.

36. Carney RM, Freedland KE, Veith RC et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999; 45: 458-463.

Labels
Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 10

2007 Issue 10

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#